Objectives: Many prior studies have evaluated the outcomes after open (OAR) and endovascular thoracoabdominal aortic aneurysms (TAAA) repairs. However, little is known about the differences in cost and the potential factors driving these differences. The aim of the study was to evaluate the cost differences of open vs endovascular repairs of intact TAAA, related to in-hospital complications.
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Methods days; P < .001). The median total and fixed cost of OAR was significantly higher compared to endovascular repair ($50,633 vs $40,991; P < .001) and ($21,703 vs $13,751; P < .001), respectively. The in-hospital mortality and complications including cardiac, neurologic, renal, gastrointestinal and pulmonary were all two-to three-fold higher following OAR (Fig) . Compared to other in-hospital complications, respiratory failure had the highest adjusted additional cost of $20,782 if undergoing endovascular repair, whereas neurologic complication had the highest adjusted additional cost of $20,618 after OAR. There was no significant difference in the total adjusted cost attributed to any complication when compared between open vs endovascular repairs (Table) . Furthermore, the overall adjusted total in-hospitalization cost for OAR, irrespective of complications; was $6202 (95% confidence interval, 2015-10,389; P ¼ .004) higher compared to endovascular repair.
Conclusions: In this large cohort of intact TAAAs, we showed a significantly higher adjusted total in-hospitalization cost of OAR compared to endovascular repair despite the additional cost of endografts. This is likely driven by longer length of stay and higher mortality and morbidities following OAR. Objectives: Concurrent iliac occlusion and abdominal aortic aneurysm (AAA) is rare. The usual endovascular approach for these patients is an aortouniiliac device combined with femoral-femoral crossover bypass. The aim of this study was to examine the outcomes of patients undergoing iliac recanalization and concomitant bifurcated endovascular aneurysm repair (EVAR).
Methods: We reviewed our clinical series of patients who underwent an EVAR from January 2016 to October 2016. Data regarding risk factors, comorbidities, anatomical findings, intraoperative features, and early and long-term outcomes were recorded in a dedicated database. Particular attention was paid to the outcomes of patients who underwent in our center an iliac recanalization of chronic iliac occlusions and concurrent EVAR of an infrarenal aortic aneurysm.
Results: During the index period, 58 EVAR were performed. Six of them had an AAA associated to an iliac artery disease. Mean age was 67 years (range, 55-77 years). Four patients had a common (CIA) or an external iliac artery (EIA) occlusion (in three of them it was associated with a common femoral artery occlusion). In two cases a CIA occlusion was associated with a contralateral CIA stenosis and in the remaining patient was found an EIA and a common femoral artery occlusion. We placed six cover stents (Viabahn; W. L. Gore and Associates, Flagstaff, Ariz): four in CIAs, two in EIA. In five cases we also performed a common femoral artery endarterectomy with a patch. No re-entry devices were used. We successfully implanted six bifurcated devices: two Gore Excluder (W. L. Gore and Associates), two AFX (Endologix Inc, Irvine, Calif), and two Incraft (Cordis Corp, Bridgewater, NJ) devices were used. Mean length of stay was 7 days. No major perioperative complications or deaths occurred. During a mean follow-up of 9 months (range, 2-10 months) there was 100% primary patency of recanalized iliac arteries. No aneurysm grew or rupture was recorded. One patient had a perioperative nonfatal myocardial infarction.
Conclusions: The improved facility of endovascular techniques allows treatment of both the iliac occlusion and the infrarenal aortic aneurysm in the same patient at the same time, avoiding extra-anatomic bypass. The technical success and midterm follow-up results demonstrate that this system is technically feasible and durable. Further studies with longer follow-up will be necessary to confirm the real benefits of this technique.
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